IVF

1.7600.00%
BA

Barbara A. Ryan

Independent Director

Ms. Barbara A. Ryan is Independent Director of Azitra, Inc. from June 15, 2023. She was Independent Non-Executive Director of Indivior Pharmaceuticals, Inc. (formerly known as Indivior PLC) from June 01, 2022 to November 2, 2026. She was Investor Relations Officer of Eloxx Pharmaceuticals, Inc. She is Independent Director of INVO Fertility, Inc. from September 2020. She is Director of Invea Therapeutics, Inc. from December 23, 2025. She founded Barbara Ryan Advisors, a capital markets and communications firm, in 2012 following a career on Wall Street as a sell-side research analyst covering the U.S. pharmaceutical industry. Ms. Ryan has deep experience in equity and debt financings, M&A, valuation, SEC reporting, financial analysis and corporate strategy across a broad range of life sciences companies. Ms. Ryan worked on several of the industry’s largest M&A transactions, including Shire’s defense versus a hostile takeover attempt by Abbvie, Shire’s takeover of Baxalta, Allergan’s defense against Valeant and Perrigo’s defense versus Mylan. Ms. Ryan served as an executive team member for Radius Health from January 2014 to December 2017. Previously, Ms. Ryan was a managing director at Deutsche Bank/Alex Brown and head of the company’s pharmaceutical research team and began her research career covering the pharmaceutical industry at Bear Stearns in 1982. Ms. Ryan serves as a director on the board of MiNK Therapeutics, Inc., INVO Bioscience, Inc, Invidior, PLC and The Red Door Community (formerly Gilda’s Club NYC). Ms. Ryan is the founder of Fabulous Pharma Females, a non-profit whose mission is to advance women in the biopharma industry, is a member of the editorial advisory board of Pharmaceutical Executive Magazine, a faculty member of the GLG Institute and a member of the Prix Galien executive advisory board. Ms. Ryan majored in Finance and Economics at the University of Massachusetts Amherst.

公司职务